Saphris – Think Schizophrenia or Bipolar

I suppose Saphris sounds better than asenapine.

Medical News: FDA Okays New Antipsychotic for Schizophrenia, Bipolar Disorder – in Product Alert, Prescriptions from MedPage Today

FDA approval was based on data from more than 3,000 patients showing statistically significant efficacy versus placebo in acute schizophrenia trials and statistically significant reduction of bipolar mania symptoms versus placebo.